Evolution Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Evolution Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$71.72 - $91.47 $8,319 - $10,610	-116 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$74.77 - $85.47 $13,234 - $15,128	-177 Reduced 60.41%	116 $9,000
Q1 2021 Apr 20, 2021	SELL	$74.73 - $90.69 $6,576 - $7,980	-88 Reduced 23.1%	293 $22,000
Q4 2020 Feb 02, 2021	BUY	$72.61 - $90.2 $3,122 - $3,878	43 Added 12.72%	381 $33,000
Q3 2020 Oct 15, 2020	BUY	$71.87 - $131.03 $1,437 - $2,620	20 Added 6.29%	338 $26,000
Q2 2020 Jul 27, 2020	BUY	$79.55 - $124.22 $7,318 - $11,428	92 Added 40.71%	318 $39,000
Q1 2020 Apr 22, 2020	BUY	$71.37 - $96.85 $16,129 - $21,888	226 New	226 $19,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.